TrialLeukemia2018
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma.
S Bringhen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it